XFOR Straddle Strategy
XFOR (X4 Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule selective antagonist of chemokine receptor CXCR4, which is in phase 3 clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. It has a license agreement with Abbisko Therapeutics Co Ltd. to manufacture and distribute XOLREMDI in mainland China, Taiwan, Hong Kong and Macau; Norgine to develop, manufacture, and commercialize mavorixafor in Europe, Australia, and New Zealand; and Genzyme Corporation for CXCR4 receptor to develop and commercialize products containing licensed compounds for all therapeutic, prophylactic and diagnostic uses. The company is headquartered in Boston, Massachusetts.
XFOR (X4 Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $48.3M, a beta of 0.32 versus the broader market, a 52-week range of 1.35-4.83, average daily share volume of 480K, a public-listing history dating back to 2017, approximately 143 full-time employees. These structural characteristics shape how XFOR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.32 indicates XFOR has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a straddle on XFOR?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current XFOR snapshot
As of May 15, 2026, spot at $3.94, ATM IV 410.00%, IV rank 100.00%, expected move 117.54%. The straddle on XFOR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on XFOR specifically: XFOR IV at 410.00% is rich versus its 1-year range, which makes a premium-buying XFOR straddle relatively expensive in absolute-cost terms, with a market-implied 1-standard-deviation move of approximately 117.54% (roughly $4.63 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated XFOR expiries trade a higher absolute premium for lower per-day decay. Position sizing on XFOR should anchor to the underlying notional of $3.94 per share and to the trader's directional view on XFOR stock.
XFOR straddle setup
The XFOR straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With XFOR near $3.94, the first option leg uses a $3.94 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed XFOR chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 XFOR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $3.94 | N/A |
| Buy 1 | Put | $3.94 | N/A |
XFOR straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
XFOR straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on XFOR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on XFOR
Straddles on XFOR are pure-volatility plays that profit from large moves in either direction; traders typically buy XFOR straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
XFOR thesis for this straddle
The market-implied 1-standard-deviation range for XFOR extends from approximately $-0.69 on the downside to $8.57 on the upside. A XFOR long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current XFOR IV rank near 100.00% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on XFOR at 410.00%. As a Healthcare name, XFOR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to XFOR-specific events.
XFOR straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. XFOR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move XFOR alongside the broader basket even when XFOR-specific fundamentals are unchanged. Always rebuild the position from current XFOR chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on XFOR?
- A straddle on XFOR is the straddle strategy applied to XFOR (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With XFOR stock trading near $3.94, the strikes shown on this page are snapped to the nearest listed XFOR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are XFOR straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the XFOR straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 410.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a XFOR straddle?
- The breakeven for the XFOR straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current XFOR market-implied 1-standard-deviation expected move is approximately 117.54%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on XFOR?
- Straddles on XFOR are pure-volatility plays that profit from large moves in either direction; traders typically buy XFOR straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current XFOR implied volatility affect this straddle?
- XFOR ATM IV is at 410.00% with IV rank near 100.00%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.